| Summary | AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later. |
|---|---|
| Publication Date | July 18, 2026, 5:17 a.m. |
| Registration Date | July 19, 2026, 4:16 a.m. |
| Last Update | July 21, 2026, 2:14 a.m. |
| CVSS3.1 : MEDIUM | |
| スコア | 5.5 |
|---|---|
| Vector | CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N |
| 攻撃元区分(AV) | ローカル |
| 攻撃条件の複雑さ(AC) | 低 |
| 攻撃に必要な特権レベル(PR) | 不要 |
| 利用者の関与(UI) | 要 |
| 影響の想定範囲(S) | 変更なし |
| 機密性への影響(C) | なし |
| 完全性への影響(I) | 高 |
| 可用性への影響(A) | なし |